We are delighted to welcome RosettaPath to our Seed Works shared office community of early stage life science companies.

CEO and Founder Richard Haworth, explains why he chose SBC as RosettaPath’s home:
“I chose Seed Works at Stevenage Bioscience Catalyst as a location for RosettaPath because I wanted to join a community of early stage life science companies. I was attracted by the prospect of sharing learnings, building on my professional network and working in a high quality office space.”

RosettaPath is a pathology consultancy specialising in experimental, translational and toxicologic pathology. By combining deep expertise with digital pathology and artificial intelligence tools, the team delivers high quality data and strategic insights into the human relevance of safety and efficacy findings for new medicines.

Why partner with RosettaPath?

• Trusted to help clients achieve their goals and overcome challenges
• Board-certified pathologist and toxicologist providing expert advice for life science and CRO clients
• Extensive experience in nonclinical efficacy and safety across modalities from small molecules to cell therapies
• Executive director level experience in portfolio governance

We are excited to see RosettaPath grow within our collaborative community and look forward to the impact they will bring to the life sciences sector.